Ad26.COV2-S/COVID-19-Vaccine-Pfizer-BioNTechLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1866卷 / 1期

关键词：

D O I：

10.1007/s40278-021-99711-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：15 / 15

相关论文

共 50 条

[1] Covid-19-vaccine-pfizer-biontechLack of efficacy: 5 case reports
Reactions Weekly, 2022, 1897 (1) : 133 - 133
[2] Ad26.cov2-s/covid-19-vaccine-pfizer-biontech/gsk-137173aThrombocytopenia: 3 case reports
Reactions Weekly, 2021, 1868 (1) : 18 - 18
[3] Ad26.COV2-S/RituximabProtracted COVID 19, plasma cell depletion and lack of efficacy : case report
Reactions Weekly, 2022, 1917 (1) : 24 - 24
[4] Ad26.cov2-s/azd-1222/covid-19-vaccine-pfizer-biontechVarious toxicities: 4 case reports
Reactions Weekly, 2021, 1866 (1) : 14 - 14
[5] Ad26.cov2-s/albumin-humanLack of efficacy: case report
Reactions Weekly, 2022, 1929 (1) : 16 - 16
[6] Ad26.cov2-s/elasomeranDRESS syndrome: case report
Reactions Weekly, 2022, 1927 (1) : 20 - 20
[7] Ad26.CoV2-S/heparinVarious toxicities: case report
Reactions Weekly, 2021, 1882 (1) : 23 - 23
[8] Ad26.cov2-s/elasomeranLack of efficacy:2 case reports
Reactions Weekly, 2023, 1942 (1) : 17 - 17
[9] Ad26.cov2-s/elasomeranRecurrent generalised anhidrosis: case report
Reactions Weekly, 2023, 1957 (1) : 17 - 17
[10] Ad26.COV2-S/COVID-19-Vaccine-Pfizer-BioNTec/elasomeranTransverse myelitis, chronic inflammatory demyelinating polyneuropathy and optic neuritis: 3 case reports
Reactions Weekly, 2022, 1897 (1) : 20 - 20

← 1 2 3 4 5 →